Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 10,000 shares at $7.51 ($75K) on 2019-04-15, disclosed to the SEC on 2019-04-16.
Open-market sale of $75k GNMK by SVP, Corporate Accounts. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| GNMK | SELL | 2021-02-22 | $51K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |